Covid-19 Ivermectin
- Ustvarjalec teme AndY1
- Začetni datum
Kje sem pa napisal, da bi moral objaviti svoje osebne podatke?Zakaj pa ti javno ne objaviš svojih osebnih podatkov, vključno z naslovom in telefonsko številko, ko si že tak junak.
Raje naj javnosti pove resnico glede Ivermectina, katero prikriva že več kot eno leto in se zgovarja na 'potrebujemo več študij'. Zaradi tega je strahopetec. Ali pa plačanec.
Ne vem kaj od tega je slabše.
Nazadnje urejeno:
Napisal si, da je Štrukelj strahopetec. Zanj so znani vsi osebni podatki.
Kaj imajo njegovi osebni podatki veze s čimerkoli? Pomembno je njegovo mnenje v javnosti. In njegovo mnenje glede Ivermectina je znano. Ali si ne upa povedati resnice ali je pa kaj drugega za tem.
Dosti o tem off-topicu, na katerega si zapeljal. Tema niso Štrukljevi osebni podatki.
Tule imaš review te "študije":Najnovejša študija.
Ivermectin Prophylaxis Used for COVID-19 Reduces COVID-19 Infection and Mortality Rates: A City-Wide, Prospective Observational Study of 220,517 Subjects Using Propensity Score Matching.
(PDF) Ivermectin Prophylaxis Used for COVID-19 Reduces COVID-19 Infection and Mortality Rates: A City-Wide, Prospective Observational Study of 223,128 Subjects Using Propensity Score Matching.
PDF | Updated manuscript: In January 8, 2022, we posted an updated version of our manuscript, with a few corrections. The most relevant correction was... | Find, read and cite all the research you need on ResearchGatewww.researchgate.net
Abstract
Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both COVID-19 infection and COVID-19-related comorbidities. Based on the studies suggesting efficacy in prophylaxis combined with the known safety profile of ivermectin, a citywide prevention program using ivermectin for COVID-19 was implemented in Itajai, a Southern city in Brazil in the state of Santa Catarina. The objective of this study was to evaluate the impact of regular ivermectin use on subsequent COVID-19 infection and mortality rates. Materials and methods: We analyzed data from a prospective, observational study of the citywide COVID-19 prevention with ivermectin program which occurred between July 2020 to December of 2020 in Itajaí, Brazil. Study design, institutional review board approval, and analysis of registry data occurred after completion of the program. The program consisted of inviting the entire population of Itajaí to a medical visit in order to enroll in the program and to compile baseline, personal, demographic and medical information. In the absence of contraindications, ivermectin was offered as an optional treatment to be taken 2 consecutive days every 15 days at a dose of 0.2mg/kg/day. In cases where a participating citizen of Itajai became ill with COVID-19, they were recommended to not use ivermectin or any other medication in early outpatient treatment. Clinical outcomes of infection, hospitalization, and death were automatically reported and entered into the registry in real time. Study analysis consisted of comparing ivermectin users with non-users using cohorts of infected patients propensity score matched (PSM) by age, sex, and comorbidities. COVID-19 infection and mortality rates were analyzed with and without use of propensity score matching. Results: A total of 220,517 subjects were included in the analysis; 133,051 (60.3%) regular ivermectin users and 87,466 (39.7%) non-users. Using PSM, two cohorts of 3,034 subjects suffering COVID-19 infection were compared. The regular use of ivermectin led to a 68% reduction in COVID-19 mortality [25 (0.8%) versus 79 (2.6%) among ivermectin non-users; risk ratio (RR), 0.32; 95% confidence interval (CI), 0.20 – 0.49; p < 0.0001]. When adjusted for residual variables, reduction in mortality rate was 70% (RR, 0.30; 95%CI 0.19 – 0.46; p < 0.0001). There was a 56% reduction in hospitalization rate (44 versus 99 hospitalizations among ivermectin users and non-users, respectively; RR, 0.44; 95%CI, 0.31 – 0.63; p < 0.0001). After adjustment for residual variables, reduction in hospitalization rate was 67% (RR, 0.33; 95%CI 023 – 0.66; p < 0.0001). Conclusion: In this large, propensity score matched study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.
Ivermectin study in the city of Itajaí contains several methodological weaknesses, resulting in questionable conclusions
Ivermectin is a drug used to treat parasitic infections in humans and animals. Although some studies conducted on cells growing in the lab suggest that ivermectin has antiviral properties, reliable and large-scale clinical trials in humans haven’t detected significant benefits from ivermectin...
healthfeedback.org
Preberi in se joči od vseh metodoloških napak in napačnih sklepanj.
Hja, bomo videli, kaj bo rekel peer-review.
Je pa tko, pri 220.000+ ljudeh težko nadzoruješ vse to, kar jim očitajo.
V primerjavi z Pfizerjevo študijo in vseh napak in integritete podatkov, ki so se tam dogajale, je tole mačji kašelj:
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Paul D Thacker reports In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open...
Pa je bila ena sama študija, za katero zdaj vemo, da je zmanipulirana in se na njeni podlagi cepi skoraj cel svet.
AndY1 ali samo trolaš ali resno verjameš temu čemur govoriš?
Itajaí - open study - popolnoma vsi udeleženi so bili popolnoma seznanjenimi z vsemi parametri - ali prejemajo ivermectin ali ne in vse kar posledično sledi iz tega (se pa strinjam, na tem nivoju niso naredili absolutne nobene napake, težko še karkoli drugega nehote razkriješ).
Pfizer - obstaja dvom ali so po najvišjih kriterijih skrbeli za integriteto double blinded study (ne osebje ne pacienti ne vedo kdo je v terapevtski in kdo v placebo skupini), kajti obstaja sum, da so mogoče kakšni podatki bili vidni osebju, kar bi pomenilo, da je bila študija deloma (pri nekaterih pacientih, ne vseh) degradirana na single blinded study (osebje ve, pacienti pa ne vedo ali so v terapevtski ali placebo skupini).
Še to, Pfizer - igle so metali v vreče, ne pa škatle za igle.
To je tako, kot da bi rekel, da se ________ (vstavi znamko avtomobila, ki jo ima sosed) bolj kvari (ker je crknila prednja in zadnja žarnica), se pravi DVE okvari, za razliko od ________ (vstavi tebi ljubo znamko avtomobilov ), ki je imel samo ENO okvaro (samo enkrat je disel črpalka je crknila in spravila opilke na šobe).
Poleg tega tudi niso spremljali, kdo ivermektin res jemlje in kdo ne. Domnevajo, da jih je precej jemalo neredno in marsikdo sčasoma sploh ne. Pa še demografska analiza je zanič, ker se ne ve niti, ali sta bili skupini izbrani naključno ali ne.
AndY1 ali samo trolaš ali resno verjameš temu čemur govoriš?
Itajaí - open study - popolnoma vsi udeleženi so bili popolnoma seznanjenimi z vsemi parametri - ali prejemajo ivermectin ali ne in vse kar posledično sledi iz tega (se pa strinjam, na tem nivoju niso naredili absolutne nobene napake, težko še karkoli drugega nehote razkriješ).
Pfizer - obstaja dvom ali so po najvišjih kriterijih skrbeli za integriteto double blinded study (ne osebje ne pacienti ne vedo kdo je v terapevtski in kdo v placebo skupini), kajti obstaja sum, da so mogoče kakšni podatki bili vidni osebju, kar bi pomenilo, da je bila študija deloma (pri nekaterih pacientih, ne vseh) degradirana na single blinded study (osebje ve, pacienti pa ne vedo ali so v terapevtski ali placebo skupini).
Še to, Pfizer - igle so metali v vreče, ne pa škatle za igle.
To je tako, kot da bi rekel, da se ________ (vstavi znamko avtomobila, ki jo ima sosed) bolj kvari (ker je crknila prednja in zadnja žarnica), se pravi DVE okvari, za razliko od ________ (vstavi tebi ljubo znamko avtomobilov ), ki je imel samo ENO okvaro (samo enkrat je disel črpalka je crknila in spravila opilke na šobe).
Tole si preberi in/ali poglej, pa povej, kaj od tega ne drži.
The Global Disinformation Campaign Against Ivermectin in COVID-19 (Part I)
The tactics deployed by the pharmaceutical industry in their decades-long war on generic drugs reached a zenith during COVID-19... and have resulted in true crimes against humanity.
pierrekory.substack.com
O tem sva imela že debate. Če stran nima kredibilnosti, in FLCCC s podružnicami je nima, se nima smisla z njo sploh ukvarjati.
ne ampak strani podprte z znanstveniki, ki dejansko opravijo neke raziskave po nekih obstoječih standardih in merilih. Ne pa hojladri raziskave ki nam ustreza.
Nevem jaz še na nobeni resni zadevi na koncu nisem našel tega:
Share this video with friends and family. Have
group viewing sessions on Zoom and discuss it.
• Share this video and the PDF on social media.
When you do, please use the hashtags #CCCA
and #MoreHarmThanGood
• Please join our mailing list at
www.canadiancovidcarealliance.org and we will
update you with additional evidence as we have it.
• Follow us on social media. This linktree has all our
social accounts.
Načeloma se tudi ne linka člankov v časopisju in tabloidih in te zadeve če hočeš, da te resno jemlejo.
Ampak ja če ti rečeš pol je že 100% legit to kaj tu piše. Dvoma ni ne.
Nevem jaz še na nobeni resni zadevi na koncu nisem našel tega:
Share this video with friends and family. Have
group viewing sessions on Zoom and discuss it.
• Share this video and the PDF on social media.
When you do, please use the hashtags #CCCA
and #MoreHarmThanGood
• Please join our mailing list at
www.canadiancovidcarealliance.org and we will
update you with additional evidence as we have it.
• Follow us on social media. This linktree has all our
social accounts.
Načeloma se tudi ne linka člankov v časopisju in tabloidih in te zadeve če hočeš, da te resno jemlejo.
Ampak ja če ti rečeš pol je že 100% legit to kaj tu piše. Dvoma ni ne.
Nazadnje urejeno:
